Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Surgical Innovations Group PLC Issues FY 2012 Revenue Guidance Below Analysts' Estimates
Surgical Innovations Group PLC announced that for fiscal 2012, it expects total revenue to be GBP7.6 million (FY 2011:GBP7.6 million). According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of GBP9.1 million for fiscal 2012.
Latest Developments for Surgical Innovations Group PLC
- Surgical Innovations Group PLC Receives FDA 510(k) Approval for Reusable 3mm PretzelFlex
- Surgical Innovations Group PLC Announces FDA 510(k) Approval For Reusable PretzelFlex
- Surgical Innovations Group PLC Receives FDA Clearance for Logic Range of Reusable Instruments; Company's Dealer Receives Order from Premier Healthcare Alliance
Latest Key Developments in Medical
- MIT Capital Inc Proposes To Acquire Meade Instruments Corp For $3.65 Per Share In Cash
- FDA Grants Prostate IDE Approval For Angiodynamics Inc's NanoKnife System
- Urban Ag Corp Announces It Has Entered Into The Final Stages Of Negotiations To Acquire Contractor Currently Generating $4,500,000 In Revenues
- HeartWare International Inc Receives Conditional Approval From FDA To Enroll Supplemental Patient Cohort In Destination Therapy Trial
- Share this
- Link this
- Digg this
Follow Reuters